Syneos Health Partners with Medable, Expanding Decentralized Solutions to Bring Clinical Trials Closer to the Patient
April 20, 2021 09:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C. and PALO ALTO, Calif., April 20, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, and Medable, the leading...
Real-world Evidence (RWE) Solutions Market to Reach $3.13 Billion by 2027, Growing at a CAGR of 16.5%, Says Meticulous Research®
March 15, 2021 08:30 ET
|
Meticulous Market Research Pvt. Ltd.
Redding, California, March 15, 2021 (GLOBE NEWSWIRE) -- According to a new market research report, “Real-world Evidence (RWE) Solutions Market by Component [Datasets, EMR, Services], Application...
The real world evidence (RWE) market is projected to be worth USD 4.5 billion by 2030, growing at a CAGR of 15%, claims Roots Analysis
March 03, 2021 08:45 ET
|
Roots Analysis
London, March 03, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Pharmaceutical and Life Sciences Real World Evidence Market, (2nd Edition), 2021-2030” report to its list of...
Real-World Evidence (RWE) Solutions Market Worth $3.13 billion by 2027- Exclusive Report Covering Pre and Post COVID-19 Market Analysis by Meticulous Research®
November 25, 2020 08:30 ET
|
Meticulous Market Research Pvt. Ltd.
London, Nov. 25, 2020 (GLOBE NEWSWIRE) -- According to a new market research report “Real-World Evidence (RWE) Solutions Market by Component [Datasets, EMR, Services], Application [Drug Development...
Alliance for Regenerative Medicine Calls for Multi-Stakeholder Pan-European Initiative to Fast-Track Real World Evidence in Support of Patient Access to Advanced Therapies
July 29, 2020 02:00 ET
|
The Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Calls for Multi-Stakeholder Pan-European Initiative to Fast-Track Real World Evidence in Support of Patient Access to Advanced Therapies BRUSSELS, BELGIUM. – July...
Syneos Health Releases Report Identifying Barriers to Payer Use of RWE in Rare Disease and Recommendations for Advancing Payer Engagement
November 21, 2019 09:02 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C. and NEW YORK , Nov. 21, 2019 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released “Real World Value:...
Evidation Health to Present at ISPOR 2017 on the Real Life Behavioral Factors Associated with Quality of Life
May 22, 2017 07:00 ET
|
Evidation Health, Inc.
San Mateo, CA, May 22, 2017 (GLOBE NEWSWIRE) -- Evidation Health today announces the results from a study examining the association between behavioral traits inferred from passive trackers and...
61% of Interventional Studies Are Traditional Randomized Control Trails
June 28, 2016 08:17 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - June 28, 2016) - A new study published by Cutting Edge Information discovered that 61% of interventional studies are traditional randomized control trials...